Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2012
This study will evaluate the safety and efficacy of OnabotulinumtoxinA (BOTOX®) for the treatment of urinary incontinence due to NDO in non-catheterizing patients with MS.
Epistemonikos ID: 4740381923dce385146c7291822364a5015f13ea
First added on: Mar 31, 2022